Cargando…
The application of quality by design in the development of the liquid chromatography method to determine empagliflozin in the presence of its organic impurities
Analysis of impurities is an important step in the quality control of pharmaceutical ingredients and final products. From drug synthesis or excipients, even in small concentrations, impurities may affect efficacy and safety. The method was developed following Quality by Design (QbD) for the analysis...
Autores principales: | Manoel, Joanna Wittckind, Primieri, Gabriele Bordignon, Bueno, Lívia Maronesi, Wingert, Nathalie Ribeiro, Volpato, Nádia Maria, Garcia, Cássia Virginia, Scherman Schapoval, Elfrides Eva, Steppe, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049826/ https://www.ncbi.nlm.nih.gov/pubmed/35493885 http://dx.doi.org/10.1039/c9ra08442h |
Ejemplares similares
-
In vitro toxic evaluation of two gliptins and their main impurities of synthesis
por: Giordani, Camila F. A., et al.
Publicado: (2019) -
Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
por: Heleno Ferreira, Raquel Balestri, et al.
Publicado: (2019) -
Presence of Nitrosamine Impurities in Medicinal Products
por: Sedlo, Ilijana, et al.
Publicado: (2021) -
The EU Response to the Presence of Nitrosamine Impurities in Medicines
por: Ruepp, Robin, et al.
Publicado: (2021) -
Impurity profiling and in-process testing of drugs for injection by fast liquid chromatography
por: Rocheleau, Marie-Josée, et al.
Publicado: (2012)